Latest stories

  • in

    Submit revised BE study protocol: CDSCO panel tells Laurus Labs on Carglumic Acid Dispersible Tablets

    New Delhi: Rejecting drug maker Laurus Lab’s proposal for clinical trial waiver of Carglumic acid dispersible tablets 200mg, the subject committee expert (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the firm to submit a revised bioequivalence (BE) study protocol by capturing complete details such as the objective of the study, […] More

  • in

    NMC releases revised guidelines for Faculty Development Programmes, Details

    New Delhi: Through a recent circular, the Undergraduate medical education board of the National Medical Commission has released the general guidelines for Faculty Development Programs conducted by NMC. Mentioning that these guidelines shall come into force with effect from 17th April 2023, NMC further mentioned in the circular, “Accordingly, existing guidelines issued by erstwhile MCI or […] More